Philips Ventures, the strategic venture capital arm of Philips, focuses on early- and growth-stage investments in health technology companies that align with Philips' businesses and address unmet healthcare needs. Their strategy often involves investing in companies with a potential for future acquisition by Philips.
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Stage Distribution
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PreciseDx | Series B | $11M | Jun 2025 |
| Moving Analytics | Series A | $20M | Jul 2022 |
| CVAid Medical | Series A | $4M | Feb 2022 |
| Doctor Anywhere | Series C | $65.7M | Aug 2021 |
| DiA Imaging Analysis | Series B | $14M | Aug 2021 |
| Xealth | Series A | $11M | Mar 2019 |
| American Well | Growth | $291M | Jun 2018 |
Top Co-Investors
EDBI1 shared
Square Peg Capital1 shared
Pavilion Capital1 shared
Eventide Asset Management1 shared
Merck Global Health Innovation Fund1 shared
Labcorp1 shared
McKesson Ventures1 shared
Novartis Venture Fund1 shared
Threshold Ventures1 shared
Providence Ventures1 shared
Alchimia Investments1 shared
Icon Ventures1 shared
XTX Ventures1 shared
CE Ventures1 shared
Connecticut Innovations1 shared
Mindset Venture1 shared
Last updated: 3 March 2026